Results for tag: "Sevikar"

The Sevikar market is a segment of the cardiovascular drug market that focuses on the treatment of hypertension and dyslipidemia. It includes a range of medications, such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), calcium channel blockers (CCBs), and diuretics. These drugs are used to reduce blood pressure, lower cholesterol levels, and reduce the risk of stroke and heart attack. The Sevikar market is highly competitive, with many pharmaceutical companies offering a variety of products. Some of the major players in the market include AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly innovating and developing new products to meet the needs of patients. Show Less Read more